Signaling pathways
-
BA5677 Atosiban (Standard) - BA5678 RetosibanSummary: Retosiban (GSK221149A) is a potent, selective oxytocin antagonist.
- BA5679 SHR1653Summary: SHR1653 is a potent, selective, brain-transmitting antagonist.
- BA5680 L-372662Summary: L-372662 is a potent non-peptide antagonist with oral activity.
- BA5682 trans-R-138727Summary: Trans-R-138727 is the trans isomer.
- BA5683 YM-254890Summary: YM-254890 is a selective protein inhibitor isolated from sp.
- BA5684 AR-C118925XXSummary: AR-C118925XX is a selective receptor antagonist.
- BA5685 BPTUSummary: BPTU (BMS-646786) is a non-nucleotide receptor variant antagonist with antithrombotic activity.
- BA5686 VicagrelSummary: Vicagrel is an effective and safe antiplatelet agent with oral activity that acts by irreversibly inhibiting the P2Y12 receptor.
- BA5687 PITSummary: PIT (2,2'-Pyridylisatogentosylate) is a selective and non-competitive antagonist.